1-4 of 4
Jürgen Moll
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Resistance to Danusertib (formerly PHA-739358) in BCR-ABL-Positive Cells Is Mediated by Upregulation of the Drug Transporter Abcg2 and Can Be Suppressed in Vitro by Combination Treatment with Imatinib.

Tim H Brummendorf, MD, Artur Gontarewicz, Gunhild Keller, Jürgen Moll, Melanie Braig, Imke Rohe, Edgar Jost, Oliver Galm, Carsten Bokemeyer, MD, Tessa Holyoake, Stefan Balabanov
Journal: Blood
Blood (2009) 114 (22): 1724.
https://doi.org/10.1182/blood.V114.22.1724.1724
Published: 2009
Journal Articles

Combination Therapy of Small Molecule Inhibitor PHA-739358 and Tyrosine Kinase Inhibitor Imatinib Yields Synergistic Antiproliferative Effects and Suppresses Emergence of Resistance of Chronic Myeloid Leukemia in Vitro

Stefan Balabanov, MD/PhD, Artur Gontarewicz, MD, Gunhild Keller, MD, Jürgen Moll, PhD, Carsten Bokemeyer, MD, Tessa L Holyoake, MD/PhD, Tim H. Brummendorf, MD
Journal: Blood
Blood (2008) 112 (11): 3227.
https://doi.org/10.1182/blood.V112.11.3227.3227
Published: 2008
Journal Articles

Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages

Sophia Khaldoyanidi, Jürgen Moll, Svetlana Karakhanova, Peter Herrlich, Helmut Ponta
Journal: Blood
Blood (1999) 94 (3): 940–949.
https://doi.org/10.1182/blood.V94.3.940.415k27_940_949
Published: 1999
Journal Articles

Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation

Margot Zöller, Annette Schmidt, Angela Denzel, Jürgen Moll
Journal: Blood
Blood (1997) 90 (2): 873–885.
https://doi.org/10.1182/blood.V90.2.873
Published: 1997